Filtros de búsqueda

Lista de obras de

A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma

artículo científico publicado en 2010

A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells

artículo científico publicado en 2010

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

artículo científico publicado en 2012

Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells

artículo científico publicado en 2015

Correction: Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma

scientific article published on 01 May 2019

Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma

artículo científico publicado en 2016

Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma

artículo científico publicado en 2012

Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma

artículo científico publicado en 2010

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

artículo científico publicado en 2015

PI3K/p110{delta} is a novel therapeutic target in multiple myeloma

artículo científico publicado en 2010

Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition

artículo científico publicado en 2014

The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda